SCHEMBL8915432

SCHEMBL8915432

COC(=O)C1=C(N)C(=O)O[C@@H]1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.36
HSD17B10 Q99714 4/20 0.36
CFTR P13569 1/20 0.36
KDM4E B2RXH2 7/20 0.35
HPGD P15428 3/20 0.34
HSP90AA1 P07900 1/20 0.34
PAX8 Q06710 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
TSHR P16473 3/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
GAA P10253 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31
CA14 Q9ULX7 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8918178 0.78 CA12 (0.36) ALDH1A1HSD17B10KDM4EHPGDHSP90AA1
SCHEMBL8914503 0.78 CA12 (0.36) ALDH1A1HSD17B10KDM4EHPGDHSP90AA1
SCHEMBL4293053 0.78 AKT1 (0.32)
SCHEMBL8916026 0.73 NSD2 (0.40) ALDH1A1HSD17B10KDM4EHPGDHSP90AA1
SCHEMBL8914531 0.72 HSP90AA1 (0.31) ALDH1A1HSP90AA1PAX8KMT2AGAA
SCHEMBL13602149 0.72 HSD17B10 (0.36) ALDH1A1HSD17B10KDM4EMEN1KMT2A
SCHEMBL13598135 0.68 GAA (0.34) MEN1KMT2ATSHRGAACA12
SCHEMBL10701200 0.61 MAPT (0.37) ALDH1A1HSD17B10KDM4EHPGDKMT2A
SCHEMBL17625113 0.61 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL31376171 0.60 HSP90AA1 (0.57) ALDH1A1HSD17B10KDM4EHSP90AA1PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325948-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-12-31 US disclosed
US-5625059-A Process for the manufacture of 4-acetoxy-3-hydroxyethyl-azetidinone CIBA-GEIGY CORPORATION (US) 1997-04-29 US disclosed
US-5312914-A Process for the manufacture of 4-acetoxy-3-hydroxyethyl-azetidinone CIBA-GEIGY CORP (US) 1994-05-17 US disclosed
EP-0279781-A2 Process for the preparation of 4-acetoxy-3-hydroxyethyl-acetidinone CIBA-GEIGY AG (CH) 1988-08-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325948-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE FDPS, UMPS, GGPS1 ALDH1A1 3119/4885HSD17B10 747/4885CFTR 635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.